CN1927248A - Application of semen desc urainia oil in preparation of composition with cranial nerve regulation function - Google Patents
Application of semen desc urainia oil in preparation of composition with cranial nerve regulation function Download PDFInfo
- Publication number
- CN1927248A CN1927248A CN 200510021621 CN200510021621A CN1927248A CN 1927248 A CN1927248 A CN 1927248A CN 200510021621 CN200510021621 CN 200510021621 CN 200510021621 A CN200510021621 A CN 200510021621A CN 1927248 A CN1927248 A CN 1927248A
- Authority
- CN
- China
- Prior art keywords
- group
- oil
- semen descurainiae
- model
- brain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to the application of descurainiae oil in the preparation of compounds that can regulate the cranial nerves. The compound contains descurainiae oil and other elements which are acceptable to human bodies and it can be made into different drugs, functional food and various normal foods. The main functions of the compound go as follows: improve the activity of cranial nerves so as to slow its aging; act as neurohumor and neuroceptor; promote the development of cranial nerves system and the connections between brain cells. Stabilize the nerve system and promote the recover of brain fatigue so as to enforce memories; induce the self-development and splitting of neurofibra; remodeling the neural network. The compound can be used in the assistant rehabilitative treatment of many brain diseases such as brain nerve tissue damage, resid of cerebral apoplexy, senile dementia, cerebral palsy atrophy of brain, impairment of memories, insomnia and forgetfulness.
Description
Technical field
The present invention relates to a kind of with natural plant extracts, specifically be that Semen Descurainiae oil is had application in the cranial nerve regulatory function compositions in preparation, be included in and be prepared into the application that multiple encephalopathy and symptom and sign thereof are had the aspects such as medicine, health product or food of auxiliary therapy, adjusting and rehabilitative action.
Background technology
Encephalopathy is meant the cerebral nerve tissue injury that causes because of multiple reasons such as heredity, congenital cerebral dysgenesis, cerebral trauma, the cerebral tumor, cerebral hemorrhage, cerebral infarction, infection, chemicals poisonings, and then cause symptom and sign or dysthymic one big class diseases such as patient's mental retardation, thinking, aphasis, paraesthesia, quadriplegia even gatism, common is divided three classes: the one, and the cerebral palsy of children that heredity, congenital malformation cause, mental retardation etc.; The 2nd, the acute cerebral insult sequela that wound causes, the apoplexy sequela that cerebrovascular causes etc.; The 3rd, because of the nervus centralis fibre damage and then cause the old and feeble chronic degenerative diseases of degenerating and causing of cranial nerve cell, comprise senile dementia, brain atrophy, parkinson disease and etc.; Also comprised simultaneously because the depression due to apoptosis amount and the regeneration balance destruction.
Mostly the pathological changes essence of above-mentioned various encephalopathys is to cause the cranial nerve cell afunction because nerve information conduction pathway (brain road)---the obstruction of nerve fiber causes the conduction of neural various information not smooth.For example: apoplexy is damage, obstruction, the fracture of stopping up or breaking and cause the nerve fiber conduction function owing to cerebrovascular, and then makes neurocyte degeneration, damage or death, sensation, dyskinesias such as hemiplegia, aphasia occur; Fetal brain nerve fiber impaired development, can not promote the differentiation and maturation of neurocyte, neonate ischemia, anoxia can cause the cerebral palsy based on the kentrokiness dysfunction; Big substantia nigra neuronal quantity reduces, and synthetic dopamine deficiency can cause parkinson; The aging of information conduction pathway---fiber and apoptosis aggravation cause the aging of brain cell, and the cerebral tissue atrophy can become alzheimer disease; Apoptosis amount and balance are destroyed or the irritability brain injury makes neurotransmitter systemic-function disequilibrium cause depression.
According to Epidemiological study, encephalopathy, nerve injury diseases such as cerebral infarction, cerebral hemorrhage, brain atrophy dementia, cerebral palsy of children, epilepsy, parkinson disease, cerebral trauma account for about 30% of human diseases sum.And cerebral infarction, cerebral hemorrhage etc. also have the high feature of high incidence, high mortality, high disability rate, high relapse rate etc. four.Simultaneously, as the fourth-largest illness that threatens human health, the depression sickness rate also has trend of rising gradually, threatens patient's life, influences patient's family life, increases family burden and burden on society, the loss medical resource.
Can be used for medicine that above-mentioned encephalopathy treats and/or prevents and few at present, can be more rare at the treatment prophylactic agent of encephalopathy due to all kinds of reasons.Present medicine is how just at single disease or symptom in the above-mentioned encephalopathy, and kind is single, and it is huge to treat required expense, and therapeutic use is but narrow relatively, can not meet the need of market.
Therefore, exploitation can be used for preventing and/or treating the product of above-mentioned encephalopathy, medicine, health product and/or the food etc. that for example can have the cranial nerve regulatory function, particularly according to the theory of Chinese medicine integration of edible and medicinal herbs, exploitation is the product that composition has physiological function with natural material and/or extract, has more great social significance and economic benefit.
For example, Semen Descurainiae oil involved in the present invention is that a kind of seed by the descurainia sophia (l.) webb ex prantl plant extracts and obtains the oiliness composition, is rich in the unsaturated fatty acid that comprises linolenic and linoleic etc.It is documented that Semen Descurainiae generally is to be used for cardiovascular disease and respiratory tract disease with the water decoction form.Chinese patent literature CN 1313040A report, Semen Lepidii Semen Desurainiae oil and the combination of some compositions can be used as a kind of health-care hypolipemic and antihypertensive food.CN 1326764A report, Semen Lepidii Semen Desurainiae oil and the combination of other composition can be used as the medicine with lipid-lowering effect.CN 1211443A report, Caulis et Folium Lini acid source compound oil and the multiple compositions such as linoleic acid source compound oil, Caulis et Folium Lini acid source compound oil, compound vitamin, compound microelement and compound nucleotide that contain Semen Lepidii Semen Desurainiae oil can become a kind of medicine food cosmetic dual-purpose nutrient with the irritated mottle senility and obesity of control.
Summary of the invention
In view of the foregoing, the present invention will provide a kind of Semen Descurainiae oil to have application in the cranial nerve regulatory function compositions in preparation, and by a large amount of evidences its for the encephalopathy due to a variety of causes, for example comprising because of heredity, congenital cerebral dysgenesis, cerebral trauma, the cerebral tumor, cerebral hemorrhage, cerebral infarction, infect, the cerebral nerve tissue injury that chemicals poisoning etc. causes, the apoplexy sequela, senile dementia, cerebral palsy, brain atrophy, hypomnesis, insomnia forgetfulness and depression are in interior encephalopathy, and and then the mental retardation that causes, thinking, aphasis, paraesthesia, symptom and signs such as quadriplegia even gatism or spirit depressing can have obvious effect, can be prepared into medicine and/or health product, or be prepared into modes such as numerous food as the food adding ingredient, bring into play it in the activity that improves cranial nerve, prevent the cranial nerve aging; Regulate neurotransmitter and receptor; Being connected between the development growth that promotes cerebral nervous system and brain cell; The recovery that helps stablizing nervous system and promote brain fag, thus brain improved, hypermnesis; Induce the oneself growth and the division of nerve fiber and reinvent auxiliary therapy, adjusting and the rehabilitative action of the effect aspect of neutral net.
The said Semen Descurainiae oil of the present invention has application in the cranial nerve regulatory function compositions in preparation, except that can directly using separately, better mode is and acceptable other compositions of human body, tansymustard seed oil is an active component on the south for example comprising, the said auxiliary therapy that has with the common composition of the acceptable auxiliary element of pharmacy, the relative medicine of adjusting and rehabilitative action, for example used excipient with routine, flavoring agent, disintegrating agent, antiseptic, antioxidant, lubricant, wetting agent, binding agent, solvent, thickening agent, excipient substance compositions such as solubilizing agent, be made for the tablet that is suitable for clinical use, capsule, granule, the pharmaceutical preparation of oral types such as liquid oral or injection-type, and with Semen Descurainiae oil as the food adding ingredient, with acceptable other raw materials of food production, have said auxiliary therapy common the composition, the corresponding food of adjusting and rehabilitative action, for example Semen Descurainiae oil is mixed with other food composition and be made for corresponding food, as mixed oil with the conventional mode of production, various ways such as milk powder have health care, the food of adjusting and recovery function.
Above-mentioned said Semen Descurainiae oil, be the extract that derives from the seed Semen Descurainiae of natural Chinese medicine wild plant descurainia sophia (l.) webb ex prantl (Descurania sophia (L.) Webb.ex Prantl) among the people and commonly used clinically, can extract with reference to the mode of now having reported or having used that comprises above-mentioned document and obtain.
The said Semen Descurainiae oil of the present invention can be confirmed by following result of the test in the remarkable effect that is had aspect the cranial nerve regulatory function.The Semen Descurainiae oil of wherein testing used each dosage group all is the methods that adopt above-mentioned bibliographical information, is obtained by the Semen Descurainiae extraction.
One, Semen Descurainiae oil is to the influence of quick aging brain atrophy model mice SOD, MDA, CAT, GSH-Px
Laboratory animal: 120 of the SAM-P/10 mices at 2 monthly ages of picked at random, respectively 15 of heavy dose of, middle dosage, low dose, positive controls, model group, and choosing is organized male and female half and half in contrast with SAM-R/1 mice of strain normal aging
Experimental technique: Semen Descurainiae hydraulic fluid port clothes high dose group (40ml/Kg), middle dosage group (20ml/Kg), low dose group (10ml/Kg) and positive controls (Piracetam Tablet 240mg/Kg) gastric infusion every day, model group and normal control group give equivalent normal saline filling stomach every day.The mice administration divides 3 batches after January, April, July, every group each 10, sacrificed by decapitation is got brain on the ice platform fast, and the preparation tissue homogenate is got supernatant and carried out SOD, MDA, CAT, GSH-Px detection.
Experimental result: Semen Descurainiae innage, middle dosage group can improve the activity of quick aging brain atrophy model mice SOD, CAT and GSH-Px, compare with model group to have significant difference (P＜0.01,0.05); Rising to model mice MDA has significant inhibitory effect (P＜0.01,0.05), and result of the test is shown in table 1,2,3.Experimental result explanation Semen Descurainiae oil has treatment and preventive effect to brain atrophy.
The influence of table 1 couple administration quick aging in January brain atrophy model mice SOD, MDA, CAT, GSH-Px
| Group | SOD(NU/mg*pr) | MDA(nmol/mg*pr) | CAT(NU/mg*pr) | GSH-PX(U/mg*pr) |
| Dosage group low dose group positive drug group in the normal control group model group high dose group | 54.6±2.01 45.29±3.15 ** 52.3±2.01 ΔΔ 50.2±2.36 ΔΔ 47.2±2.33 Δ 50.9±2.04 ΔΔ | 1.08±0.42 1.75±0.36 * 1.13±0.39 ΔΔ 1.32±0.61 Δ 1.63±0.54 Δ 1.22±0.31 ΔΔ | 15.2±1.26 12.75±3.55 ** 14.8±1.33 ΔΔ 13.7±1.26 Δ 13.1±1.59 Δ 14.2±1.22 ΔΔ | 18.11±1.6 15.49±2.87 * 17.2±1.86 ΔΔ 16.5±1.65 Δ 15.77±2.24 Δ 16.9±1.32 ΔΔ |
Annotate: compare with the normal control group: * * P＜0.01, * P＜0.05; Compare with model group: Δ Δ P＜0.01, Δ P＜0.05.
The influence of table 2 couple administration quick aging in April brain atrophy model mice SOD, MDA, CAT, GSH-Px
| Group | SOD(NU/mg*pr) | MDA(nmol/mg*pr) | CAT(NU/mg*pr) | GSH-PX(U/mg*pr) |
| Dosage group low dose group positive drug group in the normal control group model group high dose group | 48.41±3.21 42.64±3.25 ** 46.32±3.21 ΔΔ 45.01±3.10 ΔΔ 43.59±3.08 Δ 45.61±3.02 ΔΔ | 1.45±0.26 2.51±1.22 ** 1.71±0.21 ΔΔ 1.98±0.28 Δ 2.15±0.33 1.96±0.22 ΔΔ | 14.24±2.79 6.16±1.24 ** 13.01±2.34 ΔΔ 11.29±1.33 ΔΔ 9.88±1.09 Δ 12.58±2.53 ΔΔ | 17.1±2.39 8.05±2.14 ** 15.61±2.11 ΔΔ 13.24±2.55 ΔΔ 9.25±2.38 12.33±2.55 ΔΔ |
Annotate: compare with the normal control group: * * P＜0.01; Compare with model group: Δ Δ P＜0.01, Δ P＜0.05.
The influence of table 3 couple administration quick aging in July brain atrophy model mice SOD, MDA, CAT, GSH-Px
| Group | SOD(NU/mg*pr) | MDA(nmol/mg*pr) | CAT(NU/mg*pr) | GSH-PX(U/mg*pr) |
| Dosage group low dose group positive drug group in the normal control group model group high dose group | 47.17±6.32 39.42±3.02 ** 46.89±3.36 ΔΔ 44.39±3.05 Δ 40.65±2.38 45.26±2.56 ΔΔ | 3.11±1.66 4.24±1.59 * 3.15±1.16 Δ 3.53±0.92 Δ 4.01±0.97 3.33±1.21 Δ | 10.13±3.71 4.32±1.25 ** 9.98±1.69 ΔΔ 7.33±0.98 ΔΔ 6.31±1.39 Δ 8.97±1.22 ΔΔ | 15.23±1.27 5.19±2.68 ** 14.29±1.25 ΔΔ 10.26±1.66 ΔΔ 7.12±3.05 Δ 13.29±1.75 ΔΔ |
Annotate: compare with the normal control group: * * P＜0.01, * P＜0.05; Compare with model group: Δ Δ P＜0.01, Δ P＜0.05.
Two, Semen Descurainiae oil is to the influence of experimental mice closure cerebral trauma
Laboratory animal: treating excess syndrome is tested 60 of mices, is divided into 6 groups at random, i.e. the high, medium and low dosage group of tansymustard seed oil, and dosage is respectively 40ml/Kg, 20ml/Kg, 10ml/Kg, piracetam group 240mg/Kg, model group and normal control group, 10 every group.Gastric infusion, every day 1 time, for three days on end, normal group and model group such as give at the normal saline of capacity.40min after the last administration, except that normal group, other are respectively organized the mice etherization, be fixed on then on the bottom platform of homemade freely falling body brain injury device, impact hammer tip with the about 4mm of diameter withstands on 2～4mm place, mice cranium brain sagittal plane left side, get the 50g counterweight, freely fall, duplicate closure cerebral trauma mouse model by impact hammer from the 18cm eminence.
Experimental technique:
1, to the breathe influence of time of closure cerebral trauma model mice broken end
Press above method with experiment mice grouping, administration, modeling.8h after the modeling breaks end at mice biauricular line place fast with shears, and record is breathed the time.
2, to the influence of closure cerebral trauma model mice blood brain barrier (BBB)
Press above method with experiment mice grouping, administration, modeling.18h after the modeling, tail vein injection azovan blue solution (dosage 25mg/kg).Injection back 6h, mice is put to death in the cervical vertebra dislocation, gets the cerebral tissue oven dry.The dried cerebral tissue azovan blue of colorimetric method for determining content.
3, to the influence of closure cerebral trauma model mice cerebral index and brain water content
Press above method with experiment mice grouping, administration, modeling.4h after the modeling, mice is put to death in cervical vertebra dislocation, cuts skull rapidly open and gets cerebral tissue and claim weight in wet base, and the cerebral tissue that will wet is put in 50 ℃ of baking ovens and is toasted 24h, weighs.Calculate brain water content and cerebral index.Brain water content=(weight in wet base-dry weight)/weight in wet base * 100%, cerebral index=cutaneous horn weight * 100f body weight.
4, to the influence of closure cerebral trauma model mice cerebral tissue TNF-α and Serum ET content
Press above method with experiment mice grouping, administration, modeling.18h after the modeling, the sacrificed by decapitation mice is got blood, and centrifugalize serum is put the method for exempting from and is measured Serum ET content.Get cerebral tissue, every 1g cerebral tissue adds the acetic acid of 10mL 0.1%, boils 10min, grinds to form homogenate, and 4 ℃ of centrifugal 10min of 3000r/min get supernatant, puts the method for exempting from and measures cerebral tissue TNF-alpha content.
Experimental result:
1. high, medium and low dosage group all can be breathed the time by significant prolongation model mice broken end, with model group significant difference (P＜0.01,0.05) is arranged relatively.The results are shown in Table 4.
The breathe influence (n=10) of time of table 4 pair closure cerebral trauma model mice broken end
| Group | (s) breathes the time |
| Dosage group low dose group positive drug group in the normal control group model group high dose group | 23.5±2.3 12.6±3.9 ** 18.3±3.4 ΔΔ 16.2±2.1 ΔΔ 14.2±2.9 Δ 15.6±3.3 ΔΔ |
Annotate: compare with the normal control group: * * P＜0.01; Compare with model group: Δ Δ P＜0.01, Δ P＜0.05.
2. high, middle dosage group can significantly reduce model mice cerebral tissue azovan blue content, with model group significant difference (P＜0.01,0.05) is arranged relatively.The results are shown in Table 5.
The influence (n=10) of table 5 pair closure cerebral trauma model mice cerebral tissue azovan blue content
| Group | Azovan blue content (μ g/g) |
| Dosage group low dose group positive drug group in the normal control group model group high dose group | 27.16±7.29 61.22±18.35 ** 35.66±6.59 ΔΔ 40.25±5.97 ΔΔ 48.22±9.24 Δ 38.7±8.27 ΔΔ |
Annotate: compare with the normal control group: * * P＜0.01; Compare with model group: Δ Δ P＜0.01, Δ P＜0.05.
3. high, middle dosage group all can significantly reduce model mice brain water content and cerebral index, with model group significant difference (P＜0.01,0.05) is arranged relatively.The results are shown in Table 6.
The influence (n=10) of table 6 pair closure cerebral trauma model mice brain water content and cerebral index
| Group | Brain water content (%) | Cerebral index |
| Dosage group low dose group positive drug group in the normal control group model group high dose group | 77.51±0.45 78.21±0.42 * 77.58±0.41 Δ 77.86±0.40 78.01±0.49 77.83±0.44 Δ | 1.95±0.25 2.21±0.26 ** 2.07±0.22 ΔΔ 2.14±0.26 Δ 2.22±0.24 2.05±0.27 ΔΔ |
Annotate: compare with the normal control group: * * P＜0.01, * P＜0.05; Compare with model group: Δ Δ P＜0.01, Δ P＜0.05.
The Semen Descurainiae innage, in, low dose group all can significantly reduce model mice TNF-alpha content, and high, middle dosage group also can significantly reduce model mice Serum ET content, with model group significant difference (P＜0.01,0.05) is arranged relatively.The results are shown in Table 7.
Table 7 couple closure cerebral trauma model mice cerebral tissue TNF-only reaches the influence (n=10) of Serum ET content
| Group | TNF-alpha content (ng/g) | ET content (pg/ml) |
| Dosage group low dose group positive drug group in the normal control group model group high dose group | 25.77±7.39 39.24±9.25 ** 27.66±7.66 ΔΔ 31.69±8.22 Δ 35.58±7.25 30.57±8.69 ΔΔ | 128.39±40.22 229.07±50.32 ** 150.60±30.88 ΔΔ 182.22±45.60 Δ 208.65±47.26 174.23±40.69 ΔΔ |
Annotate: compare with the normal control group: * * P＜0.01; Compare with model group: Δ Δ P＜0.01, Δ P＜0.05.
Above experimental result explanation, Semen Descurainiae oil has certain therapeutical effect to experimental cerebral trauma.
Three, Semen Descurainiae oil is to the influence of parkinsonism
1, Semen Descurainiae oil causes the influence that mice is trembled to the oxygenate tremorine
Experimental model is made and grouping: select Kunming mouse male and female half and half for use, 16 every group, body weight 22-26 gram is divided into 5 groups, i.e. (1) model group at random; 2) madopar group; (3) Semen Descurainiae oil small dose group; (4) swash the dosage group in the Semen Descurainiae oil; (5) the heavy dose of group of Semen Descurainiae oil.Model group gives the equivalent normal saline every day and irritates stomach.(2) group is irritated madopar 120mg/kg every day, (3) group Guannan tansymustard seed oil 40ml/Kg every day, (4) group Guannan tansymustard seed oil 20ml/Kg every day, (5) group Guannan tansymustard seed oil 10ml/Kg every day, continuous 14 days.60min lumbar injection oxygenate tremorine (0.15mg/kg) after the last administration.Electrode inserts the right back limbs of mice, writes down incubation period, the persistent period of trembling and the tremor amplitude that trembling appears in animal with polygraph.The result carries out statistical procedures.
Experimental result: behind the model group mouse peritoneal injection M cholinergic receptor agonist oxygenate tremorine, show as be all of a tremble, the back of a bow, perpendicular tail, with sialorrhea, shed tears, symptom such as defecation.Compare with model group, the low dose group tremor amplitude significantly reduces (P＜0.01) in the Semen Descurainiae innage; Semen Descurainiae innage dosage group persistent period of trembling obviously shortens (P＜0.05), and three dosage groups of Semen Descurainiae oil are trembled and do not seen obvious change incubation period.Contrast medicine madopar group tremble incubation period, the persistent period of trembling and tremor amplitude there is no obvious change, the results are shown in Table 8.
Table 8 Semen Descurainiae oil causes the tremble influence of model of mice to the oxygenate tremorine
| Group | N | Incubation period/min | Persistent period/min | Tremor amplitude/min |
| The heavy dose of group of dosage group positive drug group in the model group small dose group | 16 15 16 15 15 | 0.5±1.6 1.1±1.9 2.2±2.5 1.0±1.7 1.1±1.7 | 23.6±6.4 20.8±12.2 18.4±9.6 14.6±11.4* 28.8±2.6 | 12.9±4.9 9.7±7.7 6.7±3.5** 6.3±3.1** 11.1±2.4 |
Annotate: compare with model group: * P＜0.05, * * P＜0.01
2, Semen Descurainiae oil antagonism MPTP causes the influence of mice Parkinson disease model.
Laboratory animal is divided six groups as stated above at random, gastric infusion, once a day, continuous 21 days.Model group and administration treated animal be in the 16th day lumbar injection MPTP30mg/kg, matched group lumbar injection equal-volume normal saline, once a day, and continuous five days, 60min after the last administration, the animal taking-up brain that breaks end is rapidly weighed, and liquid nitrogen is fixed.The animal groups group adds working solution, and electronic homogenate 20s (110,000r/min), extract supernatant.The filtration packing is standby.The automatic sampler sample introduction is measured DA, DOPAC, the content of monoamine neurotransmitters such as HVA.The result is carried out statistical procedures.
Experimental result: under this experimental condition, the concentration of standard substance has good linear relationship in the 0-600ng/ml scope and between the peak area.Compare with matched group, behind the model group mouse peritoneal injection MPTP5d, DA in the brain, DOPAC, HVA equal size significantly reduce (P＜0.01); Compare with model group, the heavy dose of DA of Semen Descurainiae oil, DOPAC, HVA equal size all are significantly increased (P＜0.05), and small dose group HVA content is apparently higher than model group (P＜0.01); Madopar group DA, DOPAC, HVA equal size all obviously increase (P＜0.01), the results are shown in Table 9.
Every Borneo camphor is organized DA, DOPAC, the influence of HVA content in the table 9 pair mouse brain
| Group | n | DA(ng/g) | DOPAC(ng/g) | HVA(ng/g) |
| The heavy dose of group of dosage group positive drug group in the matched group model group small dose group | 11 11 12 10 9 11 | 2143.6±250.4 949.5±297.6 ΔΔ 1101.0±185.6 1085.1±135.3 1249.4±218.2* 4623.3±729.5** | 201.1±20.8 109.6±15.8 ΔΔ 109.8±13.1 109.1±23.6 136.8±30.0* 4650.6±1826.3** | 378.3±52.7 193.5±34.8 ΔΔ 249.8±17.5** 217.8±43.9 269.2±76.7* 3659.8±853.8** |
Annotate: compare with matched group
The Δ ΔP＜0.01; Compare with model group: * P＜0.05, * * P＜0.01
Above-mentioned experimental result explanation, Semen Descurainiae oil has significant therapeutic effect to Parkinson's disease and certain preventive effect is arranged.
Four, Semen Descurainiae oil is to the protective effect of HIBI
Experimental animal: 90 of the SD rats of newborn 7 ages in days, body weight 12～16g, the male and female dual-purpose is divided into sham operated rats at random, HIE model control group, totally 6 groups of high, medium and low three the dosage groups of Semen Descurainiae oil, cerebrolysin positive controls, every group of 15 animals.
HIE modelling and medication: rat is weighed back with 0.2 ketamine 0.1g/kg intravenous anesthesia, cut skin of neck, separate left common carotid artery, by Race method row left carotid ligation (sham operated rats is only separated not ligation), sew up wound, put 37 ℃ of people behind the rest 2h, 2h in 8% the oxygen tank makes the HIE model.Model is made high, medium and low three the dosage groups of back Semen Descurainiae oil by (40,20,10ml/Kg) gastric infusion, and the cerebrolysin positive controls is lumbar injection cerebrolysin 50ml/kg immediately, every day 1 time, 3d altogether; The isodose normal saline of model control group gastric infusion, logotype 3d; Sham operated rats is disregarded.
Each organizes the 4th day sacrificed by decapitation of rat, get brain fast, through 10% neutral formalin buffer fixedly behind the 2h, with optic chiasma, mammillary body middle part, brain trailing edge and cerebellum junction is the point of contact, brain is cut into four by crown, conventional H E colored light sem observation is carried out in routine paraffin wax embedding, section (thick about 6 μ m) respectively and situ end labeling detects apoptosis.
Experimental result: apoptosis testing result representation model matched group apoptotic cell ratio is apparently higher than sham operated rats (P＜0.01), the ratio of Semen Descurainiae high, medium and low three dosage groups of oil and cerebrolysin positive controls apoptotic cell is starkly lower than the HIE group, (P＜0.05), and do not have significant difference with sham operated rats.The results are shown in Table 10.
Table 10 is respectively organized rat cerebral tissue's apoptotic cell ratio
| Group | n | Apoptotic cell ratio (%) |
| Dosage group low dose group positive drug group in the sham operated rats model control group high dose group | 12 11 10 12 13 13 | 13.5±3.5 40.6±4.5 ** 19.7±2.5 * 24.7±3.7 * 31.6±2.9 * 16.8±2.7 * |
Annotate: compare with sham operated rats: * * P＜0.01; Compare with model control group: * P＜0.05.
The HE coloration result shows that the sham operated rats light microscopic shows that down each position structure of cerebral tissue and cell are methodically arranged, and the cellular morphology clear in structure is complete; The model control group cerebral edema is obvious, cell level confusion, and cell volume is little, endochylema shrinkage, a large amount of neurocyte necrosis; Semen Descurainiae high, medium and low three dosage groups of oil and cerebrolysin positive controls cerebral edema and neurocyte degeneration are all light than model control group.Above-mentioned result of the test explanation Semen Descurainiae oil has protective effect to HIBI.
Five, Semen Descurainiae oil is to the therapeutical effect of HIBI
Experimental animal: 90 of the SD rats of newborn 7 ages in days, body weight 12～16g, the male and female dual-purpose is divided into sham operated rats at random, HIE model control group, totally 6 groups of high, medium and low three the dosage groups of Semen Descurainiae oil, cerebrolysin positive controls, every group of 20 animals.
HIE modelling and medication: rat is weighed back with 0.2 ketamine 0.1g/kg intravenous anesthesia, cut skin of neck, separate left common carotid artery, by Race method row left carotid ligation (sham operated rats is only separated not ligation), sew up wound, put 37 ℃ of people behind the rest 2h, 2h in 8% the oxygen tank makes the HIE model.Model is made high, medium and low three the dosage groups of back Semen Descurainiae oil by (40,20,10ml/Kg) gastric infusion, and the cerebrolysin positive controls is lumbar injection cerebrolysin 50ml/kg immediately, every day 1 time, 4d altogether; The isodose normal saline of model control group gastric infusion, logotype 4d; Sham operated rats is disregarded.
Each organize laboratory animal respectively at hypoxic-ischemic after 6,24,72,96h broken end is got the left side cerebral tissue, is that the thick about 3mm of a slice is got at the point of contact forward with 2mm before the optic chiasma, gets an agreement that contracts a film or TV play to an actor or actress 3mm backward, is used to do MDA, SOD detection.Adopt thiobarbituricacid (TBA) colorimetric method for determining MDA content.Adopt azanol colorimetric method for determining SOD vigor.
Result of the test: the MDA result of the test shows, compare with sham operated rats, the content of HIE model control group MDA significantly raise at hypoxic-ischemic 6h (P＜0.01), 24h peaks, reduce gradually later on, 72h compares still significant difference (P＜0.05) with sham operated rats, although 96h is higher than sham operated rats, but compare no difference of science of statistics (P＞0.05) with sham operated rats, the model success is described.Semen Descurainiae innage dosage group and cerebrolysin positive controls and model control group compare, and MDA content has begun decline (P＜0.05) .24h and reduced particularly significantly (P＜0.01) behind hypoxic-ischemic; Dosage group and Semen Descurainiae oil low dose group and model control group are relatively in the Semen Descurainiae oil, MDA content has begun to descend behind hypoxic-ischemic, but no difference of science of statistics .24h reduces comparatively significantly (P＜0.05), and each treatment group of 72h and model control group compare, and difference is remarkable (P＞0.05) not.The results are shown in Table 11.
The SOD result of the test shows, compares with sham operated rats, and energy value 6h behind hypoxic-ischemic of HIE model control group SOD significantly reduces (P＜0.01), and 24h drops to minimum point, gos up gradually then.Though 72h obviously rises, compare with sham operated rats that still there were significant differences (P＜0.01), difference not significantly (P＞0.05) then behind the 96h.And Semen Descurainiae innage dosage group and cerebrolysin positive controls and model control group are relatively, the energy value of SOD 6h behind hypoxic-ischemic has begun rise (P＜0.05), 24h raises significantly (P＜0.01), and 96h and model control group compare, and difference is remarkable (P＞0.05) not.Dosage group and Semen Descurainiae oil low dose group and model control group are relatively in the Semen Descurainiae oil, the SOD energy value has begun to rise behind hypoxic-ischemic, but no difference of science of statistics .24h raises comparatively significantly (P＜0.05), each treatment group of 72h and model control group are relatively, difference is remarkable (P＞0.05) not, the results are shown in Table 12.Result of the test explanation Semen Descurainiae oil has therapeutical effect to HIBI.
Table 11 is respectively organized the dynamic change (nmol/mL) of the MDA of rat cerebral tissue
| Group | 6h | 24h | 72h | 96h |
| Dosage group low dose group positive drug group in the sham operated rats model control group high dose group | 97.33±3.18 142.43±3.88 ** 127.48±3.57 Δ 132.51±6.11 138.47±5.38 125.23±2.39 Δ | 97.22±3.24 165.63±5.36 ** 115.63±2.81 ΔΔ 121.73±1.49 Δ 130.61±8.74 Δ 110.15±5.45 ΔΔ | 98.29±8.58 103.95±6.19 * 99.52±7.47 101.82±4.69 102.79±5.58 97.40±1.99 | 99.13±6.47 100.27±2.79 98.33±5.61 99.87±3.76 100.31±1.67 99.78±3.74 |
Annotate: compare with sham operated rats: * * P＜0.01, * P＜0.05; Compare with model control group: Δ Δ P＜0.01, Δ P＜0.05.
Table 12 is respectively organized the dynamic change (U/mL) of the SOD of rat cerebral tissue
| Group | 6h | 24h | 72h | 96h |
| Dosage group low dose group positive drug group in the sham operated rats model control group high dose group | 1.3180±0.1087 0.4320±0.0766 ** 0.7829±0.2147 Δ 0.5817±0.1643 0.5144±0.3809 0.8341±0.1691 Δ | 1.0520±0.1068 0.2360±0.0114 ** 0.5177±0.0367 △△ 0.4280±0.0927 Δ 0.3981±0.0872 Δ 0.5328±0.1208 ΔΔ | 1.3360±0.0391 1.1560±0.6901 * 1.2793±0.7941 1.1879±0.3744 1.1692±0.5431 1.2681±0.6324 | 1.3360±0.0391 1.3020±0.0807 1.2968±0.3874 1.2783±0.5429 1.3165±0.1469 1.2820±0.0543 |
Annotate: compare with sham operated rats: * * P＜0.01, * P＜0.05; Compare with model control group: Δ Δ P＜0.01, Δ P＜0.05.
Six, tansymustard seed oil is to the mensuration of aluminum chloride moulding mice Learning and Memory
Experimental model is made and grouping: select Kunming mouse male and female half and half for use, every group 16, body weight 22-26 gram, be divided into 6 groups at random, promptly normal group, Model of Dementia group, model add piracetam group, model add Semen Descurainiae oil small dose group, model add swash the dosage group in the Semen Descurainiae oil, model adds the heavy dose of group of Semen Descurainiae oil.Normal group is irritated the normal saline of equivalent every day.All the other each groups are irritated aluminum chloride 100mg/Kg, every other day once.The positive drug group is irritated piracetam 5mg/d every day, and high, medium and low three the dosage groups of Semen Descurainiae oil are by (40,20,10ml/Kg) gastric infusion.
1, measures the learning and memory of dementia mice with the Y maze method: give mice moulding perfusion two months continuously by modelling and grouping.
With the Y maze method mice is carried out the mensuration of Learning and Memory, every mice is surveyed 10 times, write down correct and wrong number of times, and the situation of mensuration mouse memory sees Table 13 after 24 hours.Experimental result explanation Semen Descurainiae oil has significant therapeutic effect to the Learning and Memory of model mice.
Table 13 Semen Descurainiae oil is to the influence of three calorize aluminum moulding mice Learning and Memory
| Group | n | Study (errors number) | Memory (errors number) |
| Dosage group high dose group in the matched group model group positive drug group low dose group | 14 13 15 15 15 13 | 1.61±0.72 ** 4.35±1.88 2.33±1.88 ** 2.50±1.51 ** 2.19±1.17 ** 3.0±1.53 ** | 2.2±0.94 ** 3.87±1.64 2.14±1.35 ** 2.07±0.92 ** 1.69±1.08 ** 2.46±1.61 * |
Annotate: compare with model group: * P＜0.05, * * P＜0.0.
2, Semen Descurainiae oil is to the influence of the dementia mice brain biochemical indicator of aluminum chloride moulding
Each organizes mice after measuring learning and memory, and sacrificed by decapitation is got full brain (decerebellation), loses the shape seam in the center separately, and half measures brain endoperoxides lipid (MDA), and second half measures Type B list brain oxidase (MAO-B).The mensuration of MDA: make 10% brain homogenate with the 0.05M phosphate buffer, measure protein content, with the MDA content in the TBA colorimetric method for determining cerebral tissue with the Coomassie brilliant blue method.The mensuration of MAO-B in the brain: be mixed with 10% brain homogenate (pre-cooling) with the 0.2M phosphate buffer, homogenate is ultrasonic at 24Kc, and centrifugal 10min under 10000r/min goes precipitation, and supernatant is centrifugal 30min under 17000r/min.Precipitation suspends with 0.2 phosphate buffer, and promptly thick enzyme is measured the MOA-B activity with reference to the McEwen method.Experimental result sees Table 15.Experimental result explanation Semen Descurainiae oil has certain reduction effect to the dementia mice brain biochemical indicator of aluminum chloride moulding, and alzheimer disease is had significant treatment and preventive effect.
The influence of the dementia mice brain biochemical indicator that influences the aluminum chloride moulding that table 14 Semen Descurainiae oil is right
| Group | n | MDA | MOA-B |
| Dosage group high dose group in the matched group model group positive drug group low dose group | 14 13 15 15 15 13 | 13.32±0.77 ** 21.12±2.78 15.03±1.04 ** 15.01±1.05 ** 13.82±0.55 ** 17.00±0.63 ** | 54.92±6.02 ** 76.71±8.9 61.79±8.78 ** 64.74±7.33 ** 57.58±7.37 ** 65.58±4.70 ** |
Annotate: compare with model group: * P＜0.05, * * P＜0.01.
Seven, Semen Descurainiae oil is to the improvement of experimental rat cerebral ischemia
Experimental animal: SD rat (250-300g), male and female half and half are divided into 6 groups at random, every group of 15 animals.Be respectively the normal control group, model group, positive controls, the Semen Descurainiae hydraulic fluid port is obeyed high, medium and low three dosage groups.
Semen Descurainiae hydraulic fluid port clothes high dose group (40ml/Kg), middle dosage group (20ml/Kg), low dose group (10ml/Kg) and positive controls (troxerutin 100mg/kg) gastric infusion every day, normal control group give equivalent normal saline filling stomach every day.Successive administration 7d, 1h peels off and ligation rat bilateral common carotid arteries and vagus nerve with 10% chloral hydrate (467mg/kg) anesthetized rat after the last administration.Normal control group only row is performed the operation and not ligation tremulous pulse.Behind the ligation 3h, broken end is opened cranium and is got brain, and decerebrate is done, and along the brain center line brain is divided into two.Portion is weighed, and calculates cerebral index (heavy * 100/ body weight of cerebral index=brain).In 110 ℃ of baking ovens, dry to constant weight, calculate brain water content percentage ratio, brain water content percentage ratio=(weight in wet base-dry weight)/weight in wet base * 100%; Another part warp is fixed, conventional dehydration, paraffin embedding film-making, dyeing, light microscopy checking.
Result of the test: relatively there were significant differences for cerebral ischemic model group brain water content and normal control group, and brain water content increases; And various dose administration group and positive controls brain water content obviously reduce, and there were significant differences than model group; Cerebral ischemic model group and normal control group relatively cerebral index increase; Various dose administration group and positive controls cerebral index have minimizing trend, and there were significant differences than the cerebral ischemic model group for oral Semen Descurainiae innage dosage group.Illustrate that Semen Descurainiae oil has protective effect to experimental experimental rat cerebral ischemia.Result of the test sees Table 15.
Table 15 pair experimental experimental rat cerebral ischemia protective effect (X ± S)
| Medicine | n | Cerebral index | Brain water content |
| Dosage group high dose group positive drug group in the normal control model group low dose group | 12 15 15 15 15 15 | 0.0081±0.00076 0.0089±0.00078 * 0.0088±0.00145 0.00829±0.00160 Δ 0.00827±0.00160 ΔΔ 0.00854±0.00098 ΔΔ | 0.776±0.021 0.788±0.192 * 0.786±0.0178 0.792±0.0055 Δ 0.789±0.009 ΔΔ 0.722±0.181 ΔΔ |
Annotate: compare with normal group: * P＜0.05; Compare with model group:
ΔP＜0.05,
The Δ ΔP＜0.01
Eight, Semen Descurainiae oil is to the influence of rat thrombus in vivo formation
Experimental animal: SD rat (250-300g), male and female half and half are divided into 5 groups at random, every group of 10 animals.Be respectively the normal control group, model group, positive controls, oral high, medium and low three the dosage groups of tansymustard seed oil.
Semen Descurainiae hydraulic fluid port clothes high dose group (40ml/Kg), middle dosage group (20ml/Kg), low dose group (10ml/Kg) and positive controls (aspirin 50mg/kg) gastric infusion every day, normal control group give equivalent normal saline filling stomach every day.Successive administration 7d does not use pentobarbital sodium 30mgkg behind time administration 60min
-1Ip anesthesia, fixing, separate left external jugular vein and right common carotid artery, in being the polyethylene tube of 2mm, internal diameter puts No. 4 surgical threads of a long 7cm of people, use heparin-saline 50uml
-1Be full of in three sections continuous polyethylene tubes, this Guan Yiduan is inserted left external jugular vein, accurately annotate people's heparin 50ukg through this pipe other end again
-1Anticoagulant, and with in this end insertion right common carotid artery.Decontrol bulldog clamp immediately, the accurate recording blood flow stops blood flow behind the 15min.The taking-up silk thread is weighed, and it heavily is wet weight of thrombus that gross weight deducts silk thread.
Result of the test: after Semen Descurainiae oil gave mice, the same equal rat suppository weight in wet base that makes with aspirin alleviated, and analyzed by statistics, and high dose group is compared with the normal saline group and had significant difference (P＜0.05), illustrates that tansymustard seed oil has anti thrombotic action.The results are shown in Table 16.
The influence that table 16 pair rat thrombus in vivo forms
| Grouping | n | Wet weight of thrombus (mg) |
| Dosage group high dose group positive drug group in the normal control low dose group | 10 10 10 10 10 | 29.69±8.36 31.51±8.16 27.13±10.46 23.18±10.00 * 24.98±9.68 * |
Annotate: compare with normal group: * P＜0.05.
Nine, Semen Descurainiae oil is to the influence of acute type blood stasis model rat blood rheology
Experimental animal: SD rat (250-300g), male and female half and half are divided into 5 groups at random, every group of 10 animals.Be respectively model group, positive controls, positive controls, the Semen Descurainiae hydraulic fluid port is obeyed high, medium and low three dosage groups.
Semen Descurainiae hydraulic fluid port clothes high dose group (40ml/Kg), middle dosage group (20ml/Kg), low dose group (10ml/Kg) and positive controls (FUFANG DANSHEN PIAN 150mg/kg) gastric infusion every day, normal control group give equivalent normal saline filling stomach every day.Every day 1 time, 7d respectively organizes behind the 7th day filling stomach 2h and uses 1gL respectively continuously
-1An epinephrine 0.2ml/ subcutaneous injection totally 2 times, 4h carries out the clear 5min of the cold thorn of frozen water therebetween 1 time at interval, stops eating after the processing, breaks end inferior morning and gets blood.An amount of liver rope anticoagulant is measured hemorheology respectively and is learned index.
Result of the test: blood stasis model rat blood rheological characteristic is sticking, dense, coagulates change, and promptly whole blood contrast viscosity (high and low shear rate) increases, reflection " gluing ".Test shows, after Semen Descurainiae oil gives mice, the same with compound Salviae Miltiorrhizae equal make the rat blood stasis model sticking, dense, coagulate to change and obviously alleviate, the effect of invigorating blood circulation of Semen Descurainiae oil is described.The results are shown in Table 17.
The influence (n=10) of table 17 pair acute type blood stasis model rat blood rheology
| Group | Shear rate 200 | Shear rate 100 | Shear rate 50 | Shear rate 10 | Plasma viscosity |
| The heavy dose of group of dosage group positive drug group model group in the small dose group | 7.60±1.38 * 7.60±1.16 * 7.29±0.66 ** 7.90±0.99 9.15±1.94 | 7.76±0.89 * 7.96±1.23 * 7.64±0.7 * 8.29±1.01 9.62±2.22 | 8.08±0.96 * 8.48±1.33 8.14±0.77 * 8.80±1.08 10.31±2.64 | 10.15±1.75 * 10.88±1.87 10.44±1.13 11.22±1.44 13.49±4.74 | 2.59±0.99 2.73±1.01 2.64±0.72 2.56±0.57 3.00±1.36 |
Annotate: compare with model group: * P＜0.05, * * P＜0.01.
Ten, Semen Descurainiae oil is to the influence of rat clotting time
Experimental animal: SD rat (250-300g), male and female half and half are divided into 5 groups at random, every group of 10 animals.Be respectively model group, positive controls, positive controls, the Semen Descurainiae hydraulic fluid port is obeyed high, medium and low three dosage groups.
Semen Descurainiae hydraulic fluid port clothes high dose group (40ml/Kg), middle dosage group (20ml/Kg), low dose group (10ml/Kg) and positive controls (aspirin 21mg/kg) gastric infusion every day, normal control group give equivalent normal saline filling stomach every day.Successive administration 7d after the last time administration 1 hour, gets blood with glass capillary from rat ophthalmic corner of the eyes ball rear vein beard earlier.Pick up counting in the autoblood inflow pipe,, and slowly draw back to the left and right, observe blood clotting silk time of occurrence, i.e. the blood clotting time every 30 seconds about 0.5cm of the capillary tube that fractures.
Result of the test: after tansymustard seed oil gives rat, the same all obvious prolong rats clotting time with aspirin.Analyze by statistics, high dose group is compared with the normal saline group and is had significant difference (P＜0.01), illustrates that Semen Descurainiae oil has function of promoting blood circulation to disperse blood clots.The results are shown in Table 18.
Table 18 Semen Descurainiae oil is to the influence of rat clotting time
| Group | n | Clotting time (s) |
| The normal control group | 10 | 195±30 |
| Dosage group low dose group in the positive drug group high dose group | 10 10 10 10 | 144±35 ** 156±34 ** 178±35 192±45 |
Annotate: compare with normal group: * P＜0.05, * * P＜0.01.
11, Semen Descurainiae oil is to the influence of mouse tail suspension dead time
Experimental animal: KM kind mice, male and female half and half, body weight 18～22g is divided into 5 groups at random, every group of 10 animals.Be respectively the normal control group, positive controls, the Semen Descurainiae hydraulic fluid port is obeyed high, medium and low three dosage groups.
Semen Descurainiae hydraulic fluid port clothes high dose group (40ml/Kg), middle dosage group (20ml/Kg), low dose group (10ml/Kg) and positive controls (fluoxetine Hydrochloride 80mg/kg) gastric infusion every day, normal control group give equivalent normal saline filling stomach every day.Successive administration 7d, 30min is attached to the part at its afterbody 2cm place on the one horizontal waddy after the not inferior administration, makes animal become reversal of the natural order of things state, the about 5cm of its head destage face, hang both sides and separate the animal sight line with plate, observed and recorded administration group and the matched group dead time in 6min.
Result of the test: after Semen Descurainiae oil gives mice, equally with fluoxetine Hydrochloride all shorten mice and force the outstanding tail dead time, analyzing middle and high dosage group by statistics compares with the normal saline group and has significance difference (P＜0.01), though the outstanding tail dead time of low dose group shortens to some extent, but with normal saline comparing difference nonsignificance, experimental result explanation Semen Descurainiae oil can resist the depressive symptom of mice because of forcing outstanding tail to cause.See Table 19.
Table 19 Semen Descurainiae oil forces the influence of outstanding tail dead time to mice
| Group | n | Dead time (S) |
| Dosage group low dose group in the normal control group positive drug group high dose group | 10 10 10 10 10 | 140.5±53.2 40.4±29.8 ** 75.5±33.2 ** 80.4±38.2 ** 112.8±53.3 |
Annotate: compare with normal group: * P＜0.05, * * P＜0.01.
12, Semen Descurainiae oil is to the influence of mice forced swimming dead time
Experimental animal: KM kind mice, male and female half and half, body weight 18～22g is divided into 5 groups at random, every group of 10 animals.Be respectively the normal control group, positive controls, the Semen Descurainiae hydraulic fluid port is obeyed high, medium and low three dosage groups.
Semen Descurainiae hydraulic fluid port clothes high dose group (40ml/Kg), middle dosage group (20ml/Kg), low dose group (10ml/Kg) and positive controls (fluoxetine Hydrochloride 80mg/kg) gastric infusion every day, normal control group give equivalent normal saline filling stomach every day.Successive administration 7d behind time administration 30min, does not put in the water vat (2000ml beaker, high 20cm, diameter 14cm, depth of water 10cm), regulates 23～25 ℃ of water temperatures, and one in every cylinder is put and observed 6min in the water, the accumulative total dead time in the 4min behind the record mice.
Result of the test: after Semen Descurainiae oil gives mice, equally with fluoxetine Hydrochloride all shorten the mice forced swimming dead time, analyze by statistics, basic, normal, high dosage group is compared with the normal saline group and is had significant difference (P＜0.05～0.01), illustrates that Semen Descurainiae oil can resist the depressive symptom that mice is caused because of forced swimming.The results are shown in Table 20.
Table 20 Semen Descurainiae oil is to the influence of mice forced swimming dead time
| Group | n | Dead time (S) |
| Dosage group low dose group in the normal control group positive drug group high dose group | 10 10 10 10 10 | 110.5±35.2 46.4±19.1 ** 64.5±32.6 ** 69.4±38.2 ** 79.3±32.7 * |
Annotate: compare with normal group: * P＜0.05, * * P＜0.01.
13, Semen Descurainiae oil gets rid of the influence of a behavior to the inductive mice of 5-HTP
Experimental animal: KM kind mice, male and female half and half, body weight 18～22g is divided into 5 groups at random, every group of 10 animals.Be respectively the normal control group, positive controls, the Semen Descurainiae hydraulic fluid port is obeyed high, medium and low three dosage groups.
Semen Descurainiae hydraulic fluid port clothes high dose group (40ml/Kg), middle dosage group (20ml/Kg), low dose group (10ml/Kg) and positive controls (fluoxetine Hydrochloride 80mg/kg) gastric infusion every day, normal control group give equivalent normal saline filling stomach every day.Experiment o'clock is carried out in the morning 8～12, each is organized mouse stomach and gives Style Monamine Oxidase Inhibition Moclobemide 0.1g/kg, 1.5h after, irritating stomach except that the fluoxetine positive controls gives the fluoxetine Hydrochloride 80mg/kg, all the other each groups are constant by above-mentioned administration, behind the 30min, quiet notes give 10mg/kg DL-5-HTP.It is restless to inject mice performance in the near future, and positive mice characteristic occurs and gets rid of a behavior, and negative mice does not then have, and writes down the number of times that gets rid of of the interior mice of 6min behind the 10min.
Result of the test: mice 5-HTP enhancing is got rid of the head test and is shown, low dose of Semen Descurainiae oil fails to make mice to get rid of the head reaction, only when middle dosage and heavy dose, just can make mice get rid of the head performance positive, Semen Descurainiae oil suppressed the limited in one's ability of 5-HT reuptake when low dose was described, the reuptake that can significantly suppress 5-HT during escalated dose has proved that tansymustard seed oil can fetch its antidepressant effect of performance by the rephotography that suppresses 5-HT.The results are shown in Table 21.
Table 21 Semen Descurainiae oil is to the influence of mice forced swimming dead time
| Group | n | On average get rid of a number of times/only in 6 minutes |
| Dosage group low dose group in the normal control group positive drug group high dose group | 10 10 10 10 10 | 3.1±5.5 17.9±8.2 ** 9.8±5.6 ** 5.5±4.4 * 3.2±5.8 * |
Annotate: compare with normal group: * P＜0.05, * * P＜0.01.
14, the blepharoptosis degree influence of Semen Descurainiae oil to mice is caused because of reserpine
Experimental animal: KM kind mice, male and female half and half, body weight 18～22g is divided into 6 groups at random, every group of 10 animals.Be respectively the normal control group, model group, positive controls, the Semen Descurainiae hydraulic fluid port is obeyed high, medium and low three dosage groups.
Semen Descurainiae hydraulic fluid port clothes high dose group (40ml/Kg), middle dosage group (20ml/Kg), low dose group (10ml/Kg) and positive controls (fluoxetine Hydrochloride 80mg/kg) gastric infusion every day, normal control group give equivalent normal saline filling stomach every day.Successive administration 7d, behind time administration 30min, every mice is not pressed 2.5mg/kg lumbar injection reserpine (0.1ml/10g), observes the sagging situation in mice eye danger, blepharoptosis degree and body temperature during accurate recording 1h are observed situations such as spontaneous activity, ear tail color and diarrhoea.Press the Rubin grade scale, judge sag.0 degree: normally open order; 1 degree: blepharoptosis 1/4; 2 degree: blepharoptosis 1/2; 3 degree: blepharoptosis 3/4; 4 degree: eyelid is closed fully.
Result of the test: through experiment, after mice gives reserpine (2.5mg/kg), occurred the tangible ptosis, motion can not with the body temperature symptom that descends, mice all closes one's eyes, tired contracting, ear, tail skin color are gloomy, having diarrhoea to take place during 1h, with the normal mouse comparing difference utmost point significance (P＜0.01) are arranged, illustrate to behind the normal mouse lumbar injection reserpine, can cause depressed animal model.Treat for the depression model animal with Semen Descurainiae oil and fluoxetine Hydrochloride, the depressive symptom of results model animal be improved significantly, mice partly has spontaneous activity, ear, tail color are more ruddy, blepharoptosis degree and body temperature decline degree reduce, but the diarrhoea situation changes not quite.The blepharoptosis degree and the normal saline group comparing difference of the basic, normal, high dosage treated animal of Semen Descurainiae oil have than significance (P＜0.05～0.01), the descend difference of comparing with the normal saline group of the body temperature of the middle and high dosage treated animal of Semen Descurainiae oil has significance (P＜0.05), illustrates that Semen Descurainiae oil can resist the depressive symptom that mice causes because of reserpine.The results are shown in Table 22.
Table 22 Semen Descurainiae oil causes the influence (X ± S) of mice depression model to reserpine
| Group | n | The blepharoptosis degree | Body temperature (℃) |
| The normal control group | 10 | 0 | 37.0±0.69 |
| The reserpine group | 10 | 3.19±0.77 ΔΔ | 35.3±1.01 ΔΔ |
| Dosage group low dose group in the positive drug group high dose group | 10 10 10 10 | 1.44±1.26 ** 1.69±1.64 ** 1.75±1.01 * 1.88±1.24 * | 36.5±0.51 ** 36.2±0.68 * 36.1±0.50 * 36.1±1.11 |
Annotate: compare with model group: * P＜0.05, * * P＜0.01; Compare with normal group:
The Δ ΔP＜0.01.
15, toxicity is observed:
1. irritate food to mice or inject maximum administration concentration and dosage does not cause death, can not measure the median lethal dose(LD 50) of Semen Descurainiae oil.
2. carried out rat teratogenic test, Salmonella reversion test, mouse bone marrow cells micronucleus test and chromosomal aberration test with Semen Descurainiae oil, proved that this medicine does not have teratogenesis and mutagenesis.
By above every experimental result as can be seen, its new purposes in medical treatment, healthcare field has been opened up in the application to Semen Descurainiae oil that the present invention proposes.Its no obvious toxic-side effects, and raw material sources are abundant, and the method for extracting and be prepared into corresponding medicine or food there is no specific (special) requirements and restriction, and the activity improving cranial nerve prevents the cranial nerve aging; Regulate neurotransmitter and receptor; Being connected between the development growth that promotes cerebral nervous system and brain cell; The recovery that helps stablizing nervous system and promote brain fag, thus brain improved, hypermnesis; Induce the oneself growth and the division of nerve fiber and reinvent aspect such as neutral net and have ideal comprehensive pharmacological action, has the prospect that well is applied to medicine and health product, can be in the encephalopathy of treatment due to a variety of causes, as satisfied auxiliary treatment, health care and rehabilitative actions of performance such as apoplexy sequela, senile dementia, cerebral palsy, brain atrophy, hypomnesis, insomnia forgetfulness.
The specific embodiment by the following examples is described in further detail foregoing of the present invention again.But this should be interpreted as that the scope of the above-mentioned theme of the present invention only limits to following example.Do not breaking away under the above-mentioned technological thought situation of the present invention, various replacements or change according to ordinary skill knowledge and customary means are made all should comprise within the scope of the invention.
The specific embodiment
With the descurainia sophia seed Semen Descurainiae, squeeze by the conventional method of aforementioned documents report, or adopt the critical extraction of CO2, or, obtain purified Semen Descurainiae oil as raw material with modes such as organic solvent extractions, carry out following preparation.
Embodiment 1 Semen Descurainiae oil tablet medicine
Raw material: Semen Descurainiae oil 100g, starch 60g,
Lactose 30g, magnesium stearate 10g.
Preparation method: with Semen Descurainiae oil, starch, lactose mixing, after the established practice method is granulated, add the magnesium stearate granulate, tabletting is made 1000 altogether, obtains every tablet medicine that contains Semen Descurainiae oil 100mg.
Embodiment 2 Semen Descurainiae fat capsule medicines
Raw material: Semen Descurainiae oil 10Kg
Preparation method: with Semen Descurainiae oil in the usual way with adjuvant mix homogeneously commonly used such as PEG400, glycerol, tween after, in the packing of gelatine capsule, obtain Semen Descurainiae fat capsule preparation medicine with the filling machine fill.
Embodiment 3 Semen Descurainiaes oil injection medicine
Raw material: Semen Descurainiae oil 100g
Preparation method: with Semen Descurainiae oil and chemical classes (as tween 80, poloxamer etc.) or natural component (as cholesterol, lecithin, fabaceous lecithin, arabic gum, cholic acid class etc.) emulsifying agent, and at other conventional adjuvant of Emulsion injection (as antioxidant such as ascorbic acid, glutathion; Suspending agents such as Sodium Tvlose, polyvinylpyrrolidine alcohol; Antibacterial such as benzyl alcohol, methyl hydroxybenzoate) mixing is pressed oil emulsion type injection processes, makes 2000 injections altogether.Contain Semen Descurainiae oil 50mg in every injection medicine.
Embodiment 4 contains the mixed oil of Semen Descurainiae oil
Semen Descurainiae oil by proper proportion, with edible rapeseed oil, Semen Maydis oil, Oleum Arachidis hypogaeae semen, Oleum Helianthi, soybean oil, pumpkin seed oil, Petiolus Trachycarpi oil, olive oil or other forms of mixed oil mix homogeneously, is promptly obtained containing the edible blend oil of Semen Descurainiae oil.
Embodiment 5 contains the formula milk of Semen Descurainiae oil
With Semen Descurainiae oil 50-80 kilogram, skimmed milk 60-100 kilogram, Lactalbumin concentrate 3-5 kilogram, behind the lactose 16-18 kilogram mixed dissolution, press suitable water soluble vitamins and/or the trace element 0.1-0.2 kilogram of addition adding that food allows, and fatsoluble vitamin and/or cholesterol are an amount of, mixing, homogenizing, pasteurization, concentrate back usual manner spray drying.Obtain containing the formula milk 110-180 kilogram that Semen Descurainiae oil is strengthened adding ingredient.
Embodiment 6 contains the baby formula milk powder of Semen Descurainiae oil
With Semen Descurainiae oil 150-180 kilogram, behind casein and the whey powder 10-40 kilogram mixed dissolution, pressing addition that food allows, to add the salt of water soluble vitamins and trace element 0.4-0.7 kilogram and emulsifying agent, stability an amount of, mixing, homogenizing, pasteurization, concentrated back usual manner spray drying are strengthened and are added the baby formula milk powder 140-210 kilogram of Semen Descurainiae oil.
Claims (6)
1. Semen Descurainiae oil has application in the cranial nerve regulatory function compositions in preparation.
2. application as claimed in claim 1 is characterized in that by Semen Descurainiae oil be active component, with the common medicine of forming of the acceptable auxiliary element of pharmacy.
3. application as claimed in claim 2 is characterized in that said medicine is the oral type preparation.
4. application as claimed in claim 2 is characterized in that said medicine is the injection-type preparation.
5. application as claimed in claim 1, tansymustard seed oil is as the food adding ingredient, with the common food of forming of acceptable other raw materials of food production on the south it is characterized in that.
6. as the described application of one of claim 1 to 5, it is characterized in that said cranial nerve regulatory function is meant encephalopathy that comprises cranial nerve tissue injury, apoplexy sequela, senile dementia, cerebral palsy, brain atrophy, hypomnesis, insomnia forgetfulness and depression and the adjusting recovery function that symptom and sign has thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100216219A CN100382808C (en) | 2005-09-06 | 2005-09-06 | Application of semen desc urainia oil in preparation of composition with cranial nerve regulation function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100216219A CN100382808C (en) | 2005-09-06 | 2005-09-06 | Application of semen desc urainia oil in preparation of composition with cranial nerve regulation function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1927248A true CN1927248A (en) | 2007-03-14 |
| CN100382808C CN100382808C (en) | 2008-04-23 |
Family
ID=37857478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100216219A Expired - Fee Related CN100382808C (en) | 2005-09-06 | 2005-09-06 | Application of semen desc urainia oil in preparation of composition with cranial nerve regulation function |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100382808C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103153323A (en) * | 2010-09-17 | 2013-06-12 | 韩国食品研究院 | Composition for promoting memory and learning ability |
| CN107184756A (en) * | 2017-01-19 | 2017-09-22 | 吉林大学 | One kind repairs neurovascular pharmaceutical composition and preparation method thereof |
-
2005
- 2005-09-06 CN CNB2005100216219A patent/CN100382808C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103153323A (en) * | 2010-09-17 | 2013-06-12 | 韩国食品研究院 | Composition for promoting memory and learning ability |
| CN103153323B (en) * | 2010-09-17 | 2015-08-26 | 韩国食品研究院 | Memory and learning capacity enhancing compositions |
| CN107184756A (en) * | 2017-01-19 | 2017-09-22 | 吉林大学 | One kind repairs neurovascular pharmaceutical composition and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100382808C (en) | 2008-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1706280A (en) | Health food capable of raising immunity and its production process | |
| CN1927248A (en) | Application of semen desc urainia oil in preparation of composition with cranial nerve regulation function | |
| CN1887283A (en) | Medicine composition containing bailobalide | |
| CN1284790C (en) | Cornus officinalis extract, extraction method thereof and application of extract in preparation of medicines and health-care products | |
| CN101744806B (en) | Application of pinocembrin raceme in preparation of medicals for cerebral apoplexy | |
| CN1887282A (en) | Medicine composition containing bailobalide | |
| CN1319557C (en) | Chinese medicine composition for treating cardiac and cerebral vascular diseases and its prepn | |
| CN114306319A (en) | Application of nervonic acid in repairing cerebral ischemia reperfusion injury | |
| US7427663B2 (en) | Cardio myopeptidin, the production and the use thereof | |
| CN1689637A (en) | Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process | |
| CN1290566C (en) | Depression treating medicinal formulation and its preparation process | |
| CN1179735C (en) | Litholytic medicine for treating hepatolith and preparation process thereof | |
| CN1284589C (en) | Medicine for treating acute brain blood vessel disease and its preparation method | |
| CN1282470C (en) | Traditional Chinese medicine for anti depression | |
| CN1907420A (en) | Medicine for treating myocardial ischemia disease and its preparing process | |
| CN1150944C (en) | Application of alkaline fibroblast growth factor in preparing medicine to prevent and cure cerebral injury | |
| CN1205982C (en) | Xiangdan drop liquid for treating angiocardiopathy | |
| JP2024512842A (en) | Use of α-asalone in the manufacture of a drug for the prevention or treatment of hemorrhagic stroke | |
| CN1803156A (en) | Medicine for treating apoplexy and its preparing process | |
| CN101632724B (en) | Application of polygonum orientale and erigeron breviscapus composition in preparing medicaments for treating cerebrovascular disease and correlative diseases | |
| CN104940237B (en) | Crocodile blood deproteinized extract and extraction method and application thereof | |
| CN1850185A (en) | Yixinshu Injecta for retaliation of Qi and pulse and promotion of blood circulation and removing of blood stasis, and preparing method therefor | |
| CN1268364C (en) | Medicine for treating cerebral hemorrhage and its preparing method | |
| CN101732442B (en) | Application of prince feather-containing composition in preparation of medicaments for treating cerebrovascular diseases and related diseases | |
| CN1298348C (en) | Injection for treating coronary heart disease and cerebral infarction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080423 Termination date: 20200906 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |